LIVN Q2 2019 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$277M-3.6% YoY

Gross Profit

$197M71.1% margin

Operating Income

-$30M-10.8% margin

Net Income

-$29M-10.5% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

+10.5%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$25M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.6B

Total Liabilities

$1.1B

Stockholders' Equity

$1.5B

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$277M	$288M	-3.6%
Gross Profit	$197M	$194M	+1.6%
Operating Income	-$30M	$22M	-238.3%
Net Income	-$29M	$15M	-293.9%

Revenue Segments

Neuromodulation

$104M76%

Cardiac Surgery

$33M24%

Geographic Segments

Rest Of World

$656,000100%